Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 5CNS 5Sarcoma 3Thoracic 2Other hematologic neoplasm 2Lymphoid 2Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 76Lung Neoplasms 39Carcinoma, Non-Small-Cell Lung 11Ovarian Neoplasms 5Neoplasm Metastasis 5Carcinoma, Small Cell 4Uterine Cervical Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Neoplasms 2Extensive Stage Small Cell Lung Cancer 2Esophageal Neoplasms 2Carcinoma, Neuroendocrine 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1SCLC, Extensive Stage 1SCLC 1Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Unknown Primary 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Docetaxel 8pembrolizumab 7Pemetrexed 5Carboplatin 5Erlotinib Hydrochloride 4toripalimab 3rociletinib 3fludarabine 3Radiosurgery 3Paclitaxel 3Oxaliplatin 3Nivolumab 3Gemcitabine 3Etoposide 3Cyclophosphamide 3Cisplatin 3Bevacizumab 3lorlatinib 2atezolizumab 2Vinorelbine 2Topotecan 2Radiotherapy 2Platinum 2Itraconazole 2Irinotecan 2Interleukin-2 2Cetuximab 2Albumin-Bound Paclitaxel 2vinflunine 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Topotecan × Thoracic × Clear all
NCT02100007 2017-10-02

ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors

MEI Pharma, Inc.

Phase 1/2 Terminated
46 enrolled 17 charts
GynecologicThoracic

Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Small Cell Lung Carcinoma

NCT00276276 2013-04-15

Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer

GlaxoSmithKline

Phase 3 Completed
141 enrolled
Thoracic

Lung Neoplasms, Recurrence, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡